Dr. Thomas Rando

Director, UCLA Broad Stem Cell Research Center · 1 appearance on the record.

computed by AI from the episodes · how this works → · full disclaimer →

scientistacademicfoundermed.stanford.edu/profiles/thomas-rando ↗Wikipedia ↗

Dr. Thomas Rando is recognized for pioneering research in stem cell biology and tissue rejuvenation, demonstrating that circulating factors in young blood reverse aging. He is a scientific co-founder of Fountain Therapeutics and directs the Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

5statements → 4claims → 3claims resolved → 33%fully supported → 4/5average certainty → 2.4/5average debate potential →

1 supported 1 partly supported 1 contradicted 1 not checkable as stated how the 4 claims stand · each chip opens the sources

1 prediction · 3 assertions · 1 insight · every statement was checked. The prediction and assertions are the 4 claims: statements the public record can support or contradict. 3 are resolved, and 1 names no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Dr. argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

Their most notable supported claim

Assertion Supported
Rando: Infusing young blood into old animals reverses some aging phenotypes
“What we really know these days is that it does seem that if you infuse Components of a blood from a young animal into an old animal. It actually can revert some of the aging phenotypes from an old state to a younger state, which is something quite different be…”
Dr. Thomas Rando Jan 2, 2019 ▶ 7:24 a16z Podcast | The Science Of Extending Life

Their most notable contradicted claim

Assertion Contradicted
Rando: The FDA will not approve drugs to treat healthy individuals
“There's no way right now that any drug is going to be approved for treatment of healthy people.”
Dr. Thomas Rando Jan 2, 2019 ▶ 18:52 a16z Podcast | The Science Of Extending Life

Expressed certainty vs assessment result

none yet certainty 1
none yet certainty 2
none yet certainty 3
75% certainty 4
0% certainty 5

weighted support: a fully supported claim counts one, a partly supported claim counts half. Each filled bar is clickable and opens exactly those claims; "none yet" means nothing said at that certainty level has resolved yet

How they sound: speaking style how? →

269 words/min while actually speaking · 3.8 um and uh per 1k words

No argument clarity score for Dr. Thomas Rando: no usable question→answer exchanges on raw tape (a fair score needs 8+). We do not score a sample that small. Roundtable and news formats yield far fewer direct exchanges than interviews.

Measured by listening to the audio itself: 2,393 words across 1 episode of raw-level tape, transcribed verbatim with every um and uh kept, each one attributed only where the alignment onto our timed stream is unambiguous. These are measurements of speaking style. We do not rank them: across this corpus, fluency and argument quality are nearly uncorrelated (ρ≈0.2), and smooth talking does not signal clear thinking. How it's measured →

Everything Dr. Thomas Rando said on the a16z Podcast that made the record, most notable first. Filter by type, assessment or year in the ledger →

Assertion Supported
Rando: Infusing young blood into old animals reverses some aging phenotypes
“What we really know these days is that it does seem that if you infuse Components of a blood from a young animal into an old animal. It actually can revert some of the aging phenotypes from an old state to a younger state, which is something quite different be…”
Dr. Thomas Rando Jan 2, 2019 ▶ 7:24 a16z Podcast | The Science Of Extending Life
Assertion Partly supported
Rando: Young plasma clinical trial underway for early-onset Alzheimer's patients
“The company based on the kind of this work of the blood transfusions is currently conducting a trial of delivering Plasma from young individuals to patients with early onset Alzheimer's disease.”
Dr. Thomas Rando Jan 2, 2019 ▶ 22:58 a16z Podcast | The Science Of Extending Life
Insight
Rando: Science focuses on extending health span, not just life span
“There's a big discrepancy between the notion of life extension and the notion of health span extension.”
Dr. Thomas Rando Jan 2, 2019 ▶ 0:56 a16z Podcast | The Science Of Extending Life
Prediction Not checkable as stated
Rando: Biological age biomarkers will enormously accelerate longevity research
“And I think, you know, the idea of having biomarkers is going to accelerate this field enormously.”
Dr. Thomas Rando Jan 2, 2019 ▶ 6:13 a16z Podcast | The Science Of Extending Life
Assertion Contradicted
Rando: The FDA will not approve drugs to treat healthy individuals
“There's no way right now that any drug is going to be approved for treatment of healthy people.”
Dr. Thomas Rando Jan 2, 2019 ▶ 18:52 a16z Podcast | The Science Of Extending Life

Appearances (1)

EpisodeDateSpeaking time
a16z Podcast | The Science Of Extending Life Jan 2, 2019 11m
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.